June 1972 BA, University of Chicago 

June 1977 Ph.D. Biochemistry, University of Chicago 

June 1978 M.D. With Honors, University of Chicago 

1978-1981 Residency, University of Chicago 

1981-1983 Fellowship, Hematology/Oncology, UCLA. Research Advisor:  David Golde, MD

1983-1985 Fellowship, Hematology/Oncology, Univ of Chicago, Research Advisor:  Janet Rowley, MD



Medical Qualifications and Licensure

Medical License, Massachusetts  #220890

Medical License, Indiana  # 01062845A

Medical License, Illinois  #036-059447 

Medical License, Pennsylvania  #MD442710 

Diplomat in Medical Oncology, ABIM (2006, recertified 2015)

Diplomat of American Board of Internal Medicine (1981) 

Board Eligible in Hematology

Current Position

2016 to present Independent consultant, retired from clinical practice. 

Positions Held

2011-2016 Medical Oncologist, Geisinger Health System, Wilkes-Barre, PA

2006-2010 Medical Oncologist, IU Goshen Center for Cancer Care, Goshen, IN

2004-2006  Professor of Medicine, Boston University Medical Center 

2000-2004  Professor of Medicine, Molecular Genetics, and Bioengineering,Univ. of Illinois at Chicago 

1995-2000  Associate Professor of Medicine, and Department of Genetics, University of Illinois at Chicago 

1991-1995  Associate Professor of Medicine and Committee on Genetics, University of Chicago 

1985-1991  Assistant Professor of Medicine, and Committee on Genetics, University of Chicago 

Other Appointments

Chief, Section of Hematology/Oncology, Dept. of Medicine, Boston University Medical Center, April 2004 – Oct 2004.

Co-Director, Clinical Cancer Center, Boston University Medical Center, , April 2004 – Oct 2004

Head, Univ. of Illinois at Chicago, Breast Cancer Medical Oncology Clinic, 2003 – 2004

Assistant to the Director and Member of the Executive Advisory Committee, UIC Research Resource Core, 2000-2003

Head of Faculty Advisory Committee for the RRC Core Genomics Facility, 2000-2004

Program Director, “Leukemia and Hematopoiesis,” UIC Cancer Research Center, 2000-2003 

Director, Molecular Diagnostic Lab, University of Illinois at Chicago, 2000 - 2002

Director, RRC Core Genomics Facility, University of Illinois at Chicago, 2000 - 2002

Director, Family Cancer Clinic, University of Illinois at Chicago, 1996 - 2000

Associate Director, MD-PhD Program, University of Illinois at Chicago, 1999 - 2000

Director, Hematology/Oncology Fellowship Training Program, University of Illinois at Chicago, 1995 - 1998

University of Chicago Cancer Center, Program Director “Molecular Genetics of Human Tumors” 1991 - 1995

Visiting Scientist Imperial Cancer Research Foundation, Lincoln’s Inn Fields, London, England, 1991 - 1992

Molecular Oncology Diagnostic Laboratory, University of Chicago Hospitals and Clinics 1987 - 1989, Co-director

Honors and Awards

Von Willegh Visiting Fellow, Johannesburg, South Africa, May 1992

James S. McDonnell Scholar in Molecular Medicine of Cancer, 1988-1991

American Society of Hematology, Stratton-Jaffe Fellow, 1985-1988

Damon Runyon-Walter Winchell Cancer Fund, Fellow, 1983-1985

Clinical Fellow of the American Cancer Society, 1981-1982

Medical Scientist Training Program, 1972-1978

Medical Alumni Prize for presentation of research done during medical school, June , 1978

American Medical Women’s Association Award for Scholastic Achievement, June, 1978

Advisory Panels

 Grant Review Panels

  • Cancer Genetics Study Section, National Institutes of Health grant review, June 2005 to 2008
  • Penny Severns Breast and Cervical Cancer Research Fnd, IL Dept. of Public Health 2002-4
  • Leukemia Research Foundation, May 2003
  • Leukaemia Research Fund (UK), 1995 
  • Reviewer, NCI Special Panel “Director’s Challenge, Molecular Classification of Tumors”, April 2000
  • NCI, reviewer, RFA on new technology, August 1999 - April 2000
  • NIH, Human Genome Study Section, October 1997-1998
  • Department of Defense Breast Cancer Research Program (BCRP), Grants Reviewer, Sept., 1997
  • NIH, Human Genome Study Section, June, 1991 - June, 1994
  • Food and Drug Administration, Reviewer for Office of Device Evaluation, 1988-1989
  • Department of Energy, Genome Study Sections, 1989-1990

Other Federal Advisory Activity:

  • Clinical Trials Working Group, Advisory Committee to the Director of NCI, May, 1996 - 1997
  • NIH Working Group on Human Genome Mapping Databases, May, 1990

Human Genome Program Activities

  • HGM, 10.5 and HGM 11, Co-Chair for Chromosome 5, 1990 - 1992
  • Organizer and Chairman, 1st International Workshop on Human Chromosome 5, London, 1990
  • Organizer and Chairman, 2nd International Workshop on Chromosome 5, Chicago, 1992
  • Participant, First (1993), 2nd (1994) and 3rd (1996), International Workshops on Chromosome 8

Professional Society Activity

Pennsylvania Medical Society

  • Board of Directors for Luzerne County Medical Society, Jan 2015 -March 2016
  • Employed Physicians' Task Force, 2015 to present
  • Delegate to Pennsylvania Medical Society Annual House of Delegates Meeting, Hershey, PA, 2014 and 2015

American Society of Hematology:

•   Scientific Subcommittee on Clinical Laboratory Medicine, 2003 - Dec. 2006

•   Program committee, 1993

•   Nominating Committee, 1987

American Society of Clinical Oncology:

•   Scientific Subcommittee on Molecular Biology, 1993

•   Awards Selection Committee, 1990-1993

•   Public Relations Committee, 1990-1992

Cancer and Leukemia Group B:

•   Core member of Immunology and Genetics Committee, 1987 to 1995

 •   Principal Investigator of Protocols 8761, 8762 and 9265

Editorial Advisory Boards

Experimental Hematology, 2002 - 2006

Blood, 2000  - 2006

Former: Leukemia and Lymphoma; Gene Therapy; Molecular Diagnosis; Human Molecular Genetics 



  1. Westbrook, CA.  Ask an Oncologist:  Honest Answers to Difficult Questions about Cancer.  February 2012, Litle Plum Press.
  2. Westbrook, CA.  To Your Health!  The Beer Doctor on Good Beer, Good Times, and the Finer Things in Life.  July, 2014.   Little Plum Press.

SELECTED PUBLICATIONS OUT OF 105, full list available on request

  • Westbrook, CA, Groopman, JE, Golde, DW.  Hairy-cell leukemia: disease pattern and prognosis.  Cancer 54:500-6, 1984  
  • Le Beau, M, Westbrook, CA, Diaz, MO, Rowley, JD.  Evidence for two distinct c-src loci on human chromosomes 1 and 20.  Nature 312:70-71, 1984.
  • Gasson, JC, Golde, DW, Kaufman, SE, Westbrook, CA, Hewick, RM, Kaufman, RJ, Wong, GG, Temple, PA, Leary AC, Brown, EL, Orr,EC, and Clark, SC.  Molecular characterization and expression of the gene encoding human erythroid potentiating activity.  Nature 315:768-771, 1985.
  • Le Beau, MM, Westbrook, CA, Diaz, MO, Rowley, JD, and Oren, M.  Translocation of the p53 gene in t(15;17) in acute promyelocytic leukemia.  Nature 316:826-828, 1985.
  • Le Beau, MM, Westbrook, CA, Diaz, MO, and Rowley, JD.  C-src is consistently conserved in the deletion (20q) in myeloid disorders.  Proc. Natl. Acad. Sci. 82:6692-6696, 1985.
  • Westbrook, CA, Le Beau, MM, Diaz, MO, Groffen, J, and Rowley, JD.  Chromosomal localization and characterization of c-abl in the t(6;9) of acute nonlymphocytic leukemia.  Proc. Natl. Acad. Sci.  82:8742-8746, 1985.
  • Le Beau, MM, Westbrook, CA, Diaz, MO, Larson, RA, Rowley, JD, Gasson, JC, Golde, DW, and Sherr, CJ.  Evidence for the involvement of GM-CSF and FMS in the deletion (5q-) in myeloid disorders.  Science 231:984-987, 1986.
  • Westbrook, CA, Rubin, CM, Le Beau, MM, Kaminer, L, Diaz, MO, Smith, SD, and Rowley, JD.  The chromosomal breakpoint in a translocation 7,9 in a human T-cell leukemia cell line is proximal to c-abl.  Proc. Natl. Acad. Sci.  USA 84:251-255, 1987.
  • Ratain, MJ, Golomb, HM, Bardawil, RG, Vardiman, JW,  Westbrook, CA, Kaminer, LS, Lembersky, BC, Bitter, MA and Daly, K.  Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.  Blood  69:872-877, 1987.
  • Bernards A, Rubin C, Westbrook CA, Paskind M, Baltimore D.  The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia. Molecular and Cellular Biology 7:3231-3236, 1987.
  • Rubin, CM, Carrino, JJ, Dickler, MN, Leibowitz, D, Smith, SD, and Westbrook, CA. Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.  Proc. Natl. Acad. Sci.  USA 85:2795-2799, 1988.
  • Westbrook, CA. The ABL Oncogene in Human Leukemias.  Blood Reviews 2:1-8, 1988.
  • Rubin, CM, Blazar, BR, Hooberman, AL, Dickler, MN, Miller, BA, and Westbrook, CA.  A deletion/insertion polymorphism in the human BCR gene on chromosome 22.  Nucl. Acids Res.  16:8741, 1988.
  • Hooberman, AL, Rubin, CM, Barton, KP, and Westbrook, CA. Detection of the Philadelphia chromosome in acute lymphoblastic leukemia by pulsed field gel electrophoresis.   Blood  74:1101-11097, 1989.
  • Hooberman, AL, Carrino, JJ, Leibowitz, D, Rowley, JD, Le Beau, MM, Arlin, ZA, Westbrook, CA.  “Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome positive acute lymphoblastic leukemia”.  Proc. Natl. Acad. Sci. 86:4259-4263, 1989.
  • Michelassi, R, Erroi, F, Angriman, I, Westbrook, CA. Chromosome 5 allele loss in human gastric, ampillary, and pancreatic carcinomas.  Ital. J. Surg. Sciences 19:341-344, 1989.
  • Tkachuk, DC, Westbrook, CA, Andreeff, M, Donlon, RA, Clearly, ML, Homge, M, Redner, A, Gray, J, Pinkel, D.  Detection of BCR-ABL fusion in chronic myelogenous leukemia by two-color fluorescence in situ hybridization.  Science 250:559-562, 1990.
  • Westbrook, CA.  “Effect on physician-scientists of the low funding rate of NIH grant applications”.  Letter to the editor, New Engl. J. Med.  323:1283, 1990.
  • Becker, MA, Heidler, SA, Bell, GI, Seino, S, Le Beau, MM,  Westbrook, CA, Neuman, W, Shapiro, LJ, Mohandas, TK, Roesssler, BJ, Pallela, TD.  Cloning of cDNAs for human phosphorbosylpyrophosphate synthetases 1 and 2 and X chromosome localization of PRPS1 and PRPS2 genes.  Genomics 8:555-561, 1990.
  • Wasylyshyn, MI, Neuman, WL, Angriman, I, Snyder, LA, Montag, AG, Westbrook, CA, Michelassi, F.  Evidence for a new tumor-suppressor gene involved in gastrointestinal malignancies.  Surgery 110:265-269, 1991.
  • Westbrook, C., Neuman, W, Hewitt, J, Le Beau, M, Kidd, K, Williamson, R.  Report of the First International Workshop of Human Chromosome 5.  Genomics 10:1105-1109, 1991.   
  • Westbrook, CA, Neuman, WL, McPherson, J, Camper, S, Wasmuth, J, Plaetke, R and Williamson, R.  Report of the second international workshop for human chromosome 5.  Cytogenet Cell Genet 61:225-242, 1992.
  • Calabrese, G, Palka, G, Westbrook, CA and Sheer D.  Complex translocation involving Ph chromosome in a patient with typical chronic myelogenous leukemia.  Cytogenetics Cell  Genetics 63 (1):52-55, 1992.
  • Le Beau, MM, Espinosa III, R, Neuman, WL, Stock, W, Roulston, D, Larson, RA, Keinanen, M and Westbrook, CA.  Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in myeloid leukemias.  Proc. Natl. Acad. Sci.  USA 90:5484-5488, 1993..  
  • Yaremko, ML, Wasylyshyn, ML, Paulus, KL, Michelassi, F,  Westbrook, CA.  Deletion mapping reveals two regions of chromosome 8 allele loss in colorectal carcinomas.  Genes,  Chromosomes and Cancer 10:1-6, 1994.
  • Kelemen, PR, Yaremko, ML, Kim, AH, Montag, AH, Michelassi, F,  Westbrook, CA.  Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinoma.  Genes, Chromosomnes and Cancer 11:195-198, 1994.
  • Stock, W, Thirman, MJ, Diaz, MO, Rowley, JD, Bloomfield, CD, Wurster-Hill, D, Sobol, RE, Dodge, RK, Larson, RA, Westbrook, CA.  Detection of MLL gene rearrangements in adult ALL.  A Cancer and Leukemia Group B Study.  Leukemia 8:1918-1922, 1994.
  • Westbrook, CA, Chmura, SJ, Arenas, RB, Kim, S-Y, Otto, G. Human APC gene expression in rodent colonic epithelium in  vivousing liposomal gene delivery.  Human Molecular Genetics 3:2005-2010, 1994.
  • Yamaoka, LH, Westbrook, CA, Speer, MC, Cilchrist, JM, Jabs, EW, Schweins, EG, Stajich, JM, Gaskell, PC, Roses, AD, Pericak-Vance, MA.  Development of a microsatellite genetic map spanning 5q31-q33 and subsequent placement of the LGMD1 locus between D5S178 and IL9.  Neuromuscular Disorder 4:471-475, 1994.
  • Larson, RA, Dodge, RK, Burns, PC, Lee, EJ, Davey, FR, Sobol, RE, Frankel, S, Hooberman, AL, Westbrook, CA, George, SL, Bloomfield, CD, Schiffer, CA.  A five drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811.  Blood 85:2025-2037, 1995.
  • Takanishi, DM, Jr, Angriman, I, Yaremko, ML, Montag, AG,  Westbrook, CA, Michelassi, F.  Chromosome 17p allelic loss in colorectal carcinoma: Clinical significance.  Arch Surg 130(6):585-588; discussion, 588-589, 1995.
  • Yaremko, ML, Recant, WT, Westbrook, CA.  Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers.  Genes, Chromosomes and Cancer 13:186-191, 1995.
  • Speer, MC, Gilchrist, JM, Chutkow, JG, McMichael, R,  Westbrook, CA, Stajich, JM, Jorgenson, EM, Gaskell, PC, Rosi, BL, Ramesar, R, Vance JM, Yamaoka, LH, Pericak-Vance, MA. Evidence for locus heterogeneity in autosomal dominat limb-girdle muscular dystrophy.  Am. J. Hum. Genet. 57:1371-1376, 1995. 
  • Horrigan, SK, Westbrook, CA, Anne, H, Kim, AH,, Banerjee, M, Stock, W, Larson, R.  Polymerase chain reaction-based diagnosis of del(5q) in aculte myeloid leukemia and myelodysplastic syndrome identified a minimal deletion interval.  Blood   88: 2665-2670, 1996.
  • Yaremko, ML, Kutza, C, Lyzak, J, Mick, R, Recant, WM,  Westbrook, CA.  Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer.  Genes, chromsomes & cancer 16:189-195, 1996.
  • Stock, W., Westbrook, CA, Peterson, B, Arthur, DC, Szatrowski, TP, Silver, RT, Sher, DA, Wu, D, Le Beau, MM, Schiffer, CA, Bloomfield, CD.  Value of molecular monitoring during the treatment of chronic myelogenous leukemia.  J. Clin. Onc.  15:26-36, 1997.
  • Takanishi, DM, Kim, SY, Kelemen, PR, Yaremko, ML, Kim, AH, Ramesar, JE, Horrigan, SK, Montag, A, Michelassi, F, Westbrook, CA.  Chromosome 8 Losses in Colorectal Carcinoma: Localization and Correlation with Invasive Disease.  Molecular Diagnosis 2:1-8, 1997.
  • Westbrook, C.A.  Molecular subsets and prognostic factors in acute lymphoblastic leukemia.  Leukemia 11 (Suppl. 4): S8-S12, 1997.
  • Bruno, E, Horrigan, SK, Van Den Berg, D, Rozler, E, Fitting, PR, Moss, ST,  Westbrook, CA, Hoffman, R. The Smad5 gene is involved in the intracellular signaling pathways which mediate the inhibitory effects of transforming growth factor-b on human hematopoiesis. Blood. 91(6):1917-1923, 1998.
  • Kim, S.Y., Horrigan, S.K., Altenhofen, J.L., Arbieva, Z.H., Hoffman, R., Westbrook, C.A. Modification of Bacterial Artificial Clones using Cre Recombinase: Introduction of selectable markers for expression in eukaryotic cells.  Genome Research. 8:404-412, 1998.
  • Goldberg, PA, Madden, MV, Harosopos, C, Felix, R, Westbrook, C, Ramesar, R.  In a resource-poor country, mutation identification has the potential to reduce the cost of family management for hereditary non-polyposis colorectal cancer.  Dis. Colon Rectum. 41:1250-3, 1998.
  • Arbieva ZH, Banerjee K, Kim SY, Maniatis V, Horrigan SK, Westbrook CA.  High resolution physical map and transcription identification at a prostate cancer deletion interval on chromosome 8, band p22. Genome Research 10:244-257, 2000.
  • Ramesar RS, Madden MV, Felix R, Harocopos CJ, Westbrook CA, Jones G, Cruse JP, Goldberg PA.  Molecular Genetics improves the management of hereditary nonpolyposis colorectal cancer. S. African Med. Jour. 90:709-14, 2000.
  • Horrigan SK, Arbieva ZH, Xie X, Kravarusic J, Fulton N, Le T, Westbrook CA. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. Blood, 95:2372-2377, 2000.
  • Hauser MA, Horrigan SK, Salmikangas P, Torian UM, Viles KD, Dancel R ,Tim R, , Taivainen U, Bartoloni L, Gilchrist JM, Stajich JM, Gaskell PC, Gilbert JR, Vance JM, Pericak-Vance MA, Carpen O, Westbrook CA, Speer MC.  Myotillin is mutated in limb girdle muscular dystrophy 1A.  Human Molec. Genet. 9:2141-2147, 2000.
  • Westbrook CA, Hsu W-T, Chyna B, Litvak D, Raza A, Horrigan SJ. Cytogeneic and molecular features of chromosome 5 deletions in myelodysplasia . British J. of Haematology 110:847-855, 2000.
  • Xie H, Hu Z, Chyna B, Horrigan S, Westbrook CA.  Human Mortalin (HSPA9): Candidate for the Myleoid Leukemia Tumor Suppressor Gene on 5q31. Leukemia 14:2128-2134, 2000.
  • Hu ZB, Gomes I, Horrigan SK, Kravarusic J, Mar BG, Arbieva Z, Chyna B, Fulton N, Edassery S, Raza A, Westbrook CA.  A nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31.  Oncogene 20:6946-6954, 2001.
  • Szatrowski TP, Dodge RK, Reynolds C, Westbrook CA, Frankel SR, Sklar J, Stewart C, Hurd D, Kolitz JE, Velez-Garcia E, Bloomfield CD, Schiffer CA, Larson RA. Lineage-Specific treatment of adult acute lymphoblastic leukemia in first remission: CALGB Study 9311. Cancer 97:1471-1480, 2003
  • Stitziel NO, Mar, BG, Liang J, Westbrook CA, Membrane-Associated and Secreted Genes in Breast Cancer. Cancer Research, Cancer Res. 2004 64: 8682-8687..


  • Gasson JC, Chen ISY, Westbrook CA, and Golde DW.  Lymphokines and Hematopoiesis in Normal and Neoplastic Hematopoiesis, Alan R. Liss, Inc., New York.
  • Golomb HM, Ratain M, Westbrook C, and Daly K.  “The Treatment of Hairy Cell Leukemia “in:  Leukemia:  Recent Advances in Biology and Treatment.  (Eds. R.P. Gale and D.W. Golde). Alan R. Liss, Inc., N.Y.  pp. 115-724, 1985.
  • Westbrook CA, Golomb HM.  "The treatment of B-cell malignancy" in Recent Advances in Clinical Immunology, vol. 4, R.A. Thompson, editor, 1987.
  • Westbrook CA.  "Analysis of the Philadelphia Chromosome by Pulsed Field Gel  Electrophoresis " In:  Molecular Approaches to the Study and Treatment of Philadelphia Chromosome Positive Leukemia.  A. Deisseroth, editor, in press. 
  • Hooberman AL, Westbrook CA.  "Molecular Methods to Detect the Philadelphia Chromosome," Clinics in Laboratory Medicine 10: 839-855, 1990.
  • Westbrook CA and Le Beau MM.  "Deletions of 5q and Myeloid Leukemias" In:  The Causes and Consequences of Chromosomal Aberrations.  Ilan R. Kirsch, MD, Editor.  CRC Press, USA, 1993.
  • Yaremko ML, Wasylyshyn ML, Michelassi F, Westbrook CA. Oncogenes, suppressor genes, and allele losses in colon cancer. Advances in Surgery Vol. 26,  pp. 323-332, 1993, Mosby Year Book, Chicago.
  • Westbrook, CA.  “The Molecular Basis of Neoplasia” in: Hematology: Basic Principles and Practice, 4th ed. R. Hoffman, ed. Elsevier / Churchill Livingston, Philadelphia PA, 2005.  pp 941-954.









  • RESEARCH GRANTS AWARDED:  41, full list available on request
  • RESEARCH SUPERVISION  :  6 PhD students, full list available on request
  • FELLOWSHIP ADVISOR: Supervised 12 recipients, full list available on request
  • GRADUATE  TEACHING:  at Univ. of Illinois, and Univ. of Chicago, full list available on request




  • WVIA Television, Wilkes-Barre, PA, September 25, 2012 "Ask The Doctor"
  • WNIT Television,  South Bend, IN, March 2007 “Ask an Expert”
  • WFWA Television,  Fort Wayne, IN, June 2007 “PBS Healthline”
  • WFWA Television,  Fort Wayne, IN, May 2008  “PBS Healthline”
  • WFWA Television,  Fort Wayne, IN  Dec 2008  “PBS Healthline”
  • "A Bottle a Day Keeps the Doctor Away," opening speaker at the Master Brewers' Association of the Americas, Oct 8, 2015.
  • "The Abnormal Blood Count: When do I Consult?”  Cancer Update for Primary Care Physicians, Goshen Center for Cancer Care, Oct 19, 2007
  • “Principles of Cancer Treatment,” Cancer Rehabilitation Workshop, Goshen General Hospital, March 29, 2007
  • “Genetic Testing for Cancer Predisposition”. Chicago Bar Associations’ Alliance for Women, March 27, 2001, Chicago, Illinois.
  • “Diagnostic challenges in the Family Cancer Clinic: new genes, new diseases”.  Genetic Task Force of Illinois, December 8, 2000.
  • “Genetic Counseling and DNA Testing for Adult Familial Cancers”.  University of Illinois, Medical Grand Rounds,  10/14/ 1999


  • Carol A.  Westbrook.  Methods and Compositions for the Detection of Chromosomal Aberrations. U.S. Patent No. 6,025,126, Feb 15, 2000. 
  • Joe W. Gray, Daniel Pinkel, Douglas Tkachuk, Carol A. Westbrook.  “Chromosome Specific Staining to Detect Genetic Rearrangements.”  US Patent Serial No. 444,669 Dec 1989 / continuation of US Serial No. 937,793/ continuation of US Serial No. 819,314 / continuation of US Serial No. 382,094. 
  • E Brown, D Golde, R  Hewick, SC Clark, JC Gasson, Carol A. Westbrook.  "Vectors containing a gene for a protein having erythroid-potentiative activity and recombinant DNA methods for producing said protein" US Patent Application Serial No. 656,590, filed Oct. 1, 1984.  

Community Service

Medical Volunteer at the Care and Concern Free Health Clinic, Pittston, PA, 2013-2015

Liason to Care House, a non-profit residence for cancer patients, Goshen IN, August 2007 to 2009

Board of Directors, American Theater Company, Chicago Illinois, 2002-2004

Lincoln Park High School Drama Parents’ Group, founder 2000, participant 1996-2004

Pines Township, Precinct 2, Vice Precinct Captain, 2001 to 2002.

Visiting teacher, Illinois Math and Science Academy, Aurora, Illinois, Intercession mini-course, January 2003.